Case Article—Bayer New Drug Development Decision Making

References

• Beccue P (2001) Choosing a development strategy for a new product at Amgen. Interfaces 31(5):62–64.Link, Google Scholar
• Bodily SE, Allen MS (1999) A dialogue process for choosing value-creating strategies. Interfaces 29(6):16–28.Link, Google Scholar
• Corner JL, Kirkwood CW (1991) Decision analysis applications in the operations research literature, 1970-1989. Oper. Res. 39(2):206–219.Link, Google Scholar
• DiMasi JA, Grabowski HG (2007) The cost of biopharmaceutical R&D: Is biotech different? Management Decision Econom. 28:469–479.Crossref, Google Scholar
• Johnson E, Petty N (2003) Analyzing the development strategy for Apimoxin. Interfaces 33(3):57–59.Link, Google Scholar
• Keefer DL, Bodily SE (1983) Three-point approximation for continuous random variables. Management Sci. 29(5):595–609.Link, Google Scholar
• Keefer DL, Kirkwood CW, Corner JL (2004) Perspectives on decision analysis applications, 1990-2001. Decision Anal. 1(1):5–22.Crossref, Google Scholar
• Kopcso DP, Simon H, Gao A (2016) Case article–Idiopathic pulmonary fibrosis. INFORMS Trans. Ed. 16(3):104–106.Link, Google Scholar
• McNamee P, Celona J (2008) Decision Analysis for the Professional, 4th ed. (Smart Org Inc., Menlo Park, CA), http://smartorg.com/wp-content/uploads/2011/08/Decision-Analysis-for-the-Professional.pdf.Google Scholar
• Poland WB (2004) Balancing drug safety and efficacy for a go/no-go decision. Interfaces 34(2):113–116.Link, Google Scholar
• Regan PJ (2005) Professional decision modeling: Details of a short MBA practice course. INFORMS Trans. Ed. 6(1):35–52.Link, Google Scholar
• Sharpe P, Keelin T (1998) How SmithKline Beecham makes better resource-allocation decisions. Harvard Bus. Rev. 76:45–57.Google Scholar
• Shephard GG, Kirkwood CW (1994) Managing the judgmental probability elicitation process: A case study of analyst/manager interaction. IEEE Trans. Engrg. Management 41(4):414–425.Crossref, Google Scholar
• Spetzler CS, Staël von Holstein C-AS (1975) Probability encoding in decision analysis. Management Sci. 22(3):340–352.Link, Google Scholar
• Stonebraker JS (2002) How Bayer makes decisions to develop new drugs. Interfaces 32(6):77–90.Link, Google Scholar
• Stonebraker JS (2013) Product-generation transition decision making for Bayer’s hemophilia drugs: Global capacity expansion under uncertainty with supply-demand imbalances. Oper. Res. 61(5):1119–1133.Link, Google Scholar
• Syncopation Software (2020) DPL Professional 9.0 (Bangor, ME). Accessed September 21, 2021, https://www.syncopation.com/downloads/DPL_9_User_Guide.pdf.Google Scholar
• Viswanathan V, Bayney R (2004) Decision analysis to evaluate proof-of-principle trial design for a new drug candidate. Interfaces 34(3):206–207.Google Scholar